Registration and local production of essential medicines in Uganda

References

• WHO. Essential medicines. World Health Organization. n.d. http://www.who.int/topics/essential_medicines/en/. Accessed 24 Jan 2018.
   Google Scholar
• Wirtz VJ, Hogerzeil HV, Gray AL, Bigdeli M, de Joncheere CP, Ewen MA, et al. Essential medicines for universal health coverage. Lancet. 2017;389(10067):403–76.
   PubMedGoogle Scholar
• Bazargani Y, Ewen M, de Boer A, Leufkens H, Mantel-Teeuwisse A.. Essential medicines are more available than other medicines around the globe. PLoS ONE. 2014;9(2):e87576.
   Google Scholar
• WHO, UNIDO, UNCTAD, UNAIDS, UNICEF, The Global Fund. Interagency statement on promoting local production of medicines and other health technologies. 2019. https://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2019/may/20190524_local-production-medicines. Accessed 9 Dec 2019.
   Google Scholar
• WHO. Local production for access to medical products: developing a framework to improve public health. World Health Organization. 2011. http://www.who.int/phi/publications/Local_Production_Policy_Framework.pdf. Accessed 6 Feb 2018.
   Google Scholar
• Kaplan WA, Ritz LS, Vitello M. Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature. South Med Rev. 2011;4(2):51–61.
   Google Scholar
• NDP&A. The national drug policy and authority act: chapter 206. 2000. http://www.nda.or.ug/files/downloads/National%20Drug%20Policy%20&%20Authority%20Act%20Cap%20206.pdf. Accessed 24 Jan 2018.
   Google Scholar
• EAC. East African Community Regional Pharmaceutical Manufacturing Plan of Action 2012-2016. East African Community 2011. https://www.unido.org/sites/default/files/2016-01/EAC_Regional_Pharmaceutical_Manufacturing_Plan_of_Action_0.pdf. Accessed 29 Jan 2018.
   Google Scholar
• NEPAD. Launch of the East African Community (EAC) Medicines Registration Harmonization (MRH) Project. New Partnership for Africa’s Development. 2012. http://www.nepad.org/content/launch-east-african-community-eac-medicines-registration-harmonization-mrh-project-0. Accessed 29 Jan 2018.
   Google Scholar
• Almuzaini T, Choonara I, Sammons H. Substandard and counterfeit medicines: a systematic review of the literature. BMJ Open. 2013;3(8):e002923.
   Google Scholar
• WHO, DQI. Survey of the quality of selected antimalarial medicines circulating in selected African countries. World Health Organization and the Drug Quality and Information Program 2009. http://apps.who.int/medicinedocs/documents/s17069e/s17069e.pdf. Accessed 29 Jan 2018.
   Google Scholar
• OAG. Value for money audit report on the regulation of medicines in Uganda by National Drug Authority. The Republic of Uganda Office of the Auditor General. 2010. http://www.oag.go.ug/wp-content/uploads/2016/07/Regulation-of-Medicines-in-Uganda-by-National-Drug-Authority.pdf. Accessed 29 Jan 2018.
   Google Scholar
• NDA. NDA website. www.nda.or.ug. Accessed 9 Dec 2019.
   Google Scholar
• MoH. Health sector development plan 2015/16–2019/20. Ministry of Health The Republic of Uganda. 2015. http://health.go.ug/sites/default/files/Health%20Sector%20Development%20Plan%202015-16_2019-20.pdf. Accessed 29 Jan 2018.
   Google Scholar
• MoH. Essential Medicines and Health Supplies List for Uganda 2012 (EMHSLU). Ministry of Health The Republic of Uganda. 2012. http://apps.who.int/medicinedocs/documents/s21740en/s21740en.pdf. Accessed 29 Jan 2018.
   Google Scholar
• WHO. WHO List of Prequalified Medicinal Products. 2015. http://apps.who.int/prequal/query/ProductRegistry.aspx. Accessed 17 Apr 2015.
   Google Scholar
• WHO. WHO Prequalified Vaccines. n.d. https://extranet.who.int/gavi/PQ_Web/. Accessed 9 Jun 2015.
   Google Scholar
• Doua JY, Van Geertruyden J-P. Registering medicines for low-income countries: how suitable are the stringent review procedures of the World Health Organisation, the US Food and Drug Administration and the European medicines agency?Trop Med Int Health. 2014;19(1):23–36.
   PubMed Web of Science ®Google Scholar
• Moran M, Strub-Wourgaft N, Guzman J, Boulet P, Wu L, Pecoul B. Registering New Drugs for Low-Income Countries: The African Challenge. PLoS Med. 2011;8(2):e1000411.
   Google Scholar
• PATH. Medicines Regulation in the East African Community: Landscape summary report. 2016. http://www.path.org/publications/files/APP_eac_reg_summary.pdf. Accessed 30 Jan 2018.
   Google Scholar
• MoH, WHO. Uganda: pharmaceutical country profile. 2011. http://www.who.int/medicines/areas/coordination/Uganda_PharmCountryProfilefulldoc.pdf. Accessed 24 Jan 2018.
   Google Scholar
• UNIDO. Pharmaceutical Sector Profile: Uganda. United Nations Industrial Development Organization. 2010. (Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries). https://open.unido.org/api/documents/4699932/download/Pharmaceutical%20Sector%20Profile%20-%20Uganda. Accessed 30 Jan 2018.
   Google Scholar
• Muhumuza MK. Local drug manufacturers want medicine importation controlled. Daily Monitor 2016. https://www.monitor.co.ug/Business/Commodities/Local-drug-manufacturers%2D%2Dmedicine-importation-controlled/688610-3454894-e0jbu/index.html. Accessed 11 May 2020.
   Google Scholar
• MoH. National Medicines Policy. Ministry of Health The Republic of Uganda. 2015. https://health.go.ug/sites/default/files/National%20Medicines%20Policy%202015%20%286%29.pdf. Accessed 11 May 2020.
   Google Scholar
• MeTA. Medicine price components in Uganda. Medicines Transparency Alliance. 2015. http://apps.who.int/medicinedocs/documents/s22318en/s22318en.pdf. Accessed 30 Jan 2018.
   Google Scholar
• Blick B. A review to assess the monitoring of the national pharmaceutical secor strategic plan NPSSP-II. HEPS Uganda 2014. www.heps.or.ug/file-download/download/public/184. Accessed 11 May 2020.
   Google Scholar
• MoH. National pharmaceutical sector strategic plan III (2015-2020). Ministry of Health The Republic of Uganda 2015. http://health.go.ug/sites/default/files/NPSSP%20III%20%284%29ready%20for%20print.pdf. Accessed 29 Jan 2020.
   Google Scholar
• Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, et al. The availability of six tracer medicines in private medicine outlets in Uganda. J Pharm Policy Pract. 2014;7(1):18.
   PubMedGoogle Scholar
• Kaplan WA, Laing R. Paying for pharmaceutical registration in developing countries. Health Policy Plan. 2003;18(3):237–48.
   PubMed Web of Science ®Google Scholar
• Morgan SG, Yau B, Lumpkin MM.. The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries. PLOS ONE. 2017;12(8):237–48.
   Google Scholar
• Narsai K, Williams A, Mantel-Teeuwisse AK. Impact of regulatory requirements on medicine registration in African countries - perceptions and experiences of pharmaceutical companies in South Africa. South Med Rev. 2012;5(1):31–7.
   PubMedGoogle Scholar
• EFMHACA. Announcement to all applicants. www.fmhaca.gov.et/index.html. Accessed 29 Nov 2018.
   Google Scholar